82 related articles for article (PubMed ID: 6498827)
1. Serial transplantation to nude mice of an androgen-dependent pilosebaceous tumor developed in Suncus murinus.
Itami S; Takayasu S
Cancer Res; 1984 Dec; 44(12 Pt 1):5666-9. PubMed ID: 6498827
[TBL] [Abstract][Full Text] [Related]
2. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.
Kitamura Y; Uchida N; Hayata I; Yamaguchi K; Okamoto S; Narita N; Matsumoto K
Cancer Res; 1980 Dec; 40(12):4781-5. PubMed ID: 7438110
[TBL] [Abstract][Full Text] [Related]
3. An androgen-dependent pilosebaceous tumor spontaneously developed in the Japanese house musk shrew Suncus murinus.
Itami S; Takayasu S
J Steroid Biochem; 1983 Aug; 19(2):1141-6. PubMed ID: 6604195
[TBL] [Abstract][Full Text] [Related]
4. Development of androgen-independent spindle cell tumors from androgen-dependent medullary Shionogi carcinoma 115 in androgen-depleted nude mice.
Kitamura Y; Okamoto S; Hayata I; Uchida N; Yamaguchi K; Matsumoto K
Cancer Res; 1979 Nov; 39(11):4713-9. PubMed ID: 498097
[TBL] [Abstract][Full Text] [Related]
5. Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice.
Hirohashi S; Shimosato Y; Kameya T; Nagai K; Tsunematsu R
Cancer Res; 1977 Sep; 37(9):3184-9. PubMed ID: 884670
[TBL] [Abstract][Full Text] [Related]
6. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
Humphries JE; Isaacs JT
Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
[TBL] [Abstract][Full Text] [Related]
7. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice.
Ito YZ; Mashimo S; Nakazato Y; Takikawa H
Cancer Res; 1985 Oct; 45(10):5058-63. PubMed ID: 4027985
[TBL] [Abstract][Full Text] [Related]
8. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
9. Development of seven new human prostate tumor xenograft models and their histopathological characterization.
van Weerden WM; de Ridder CM; Verdaasdonk CL; Romijn JC; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Am J Pathol; 1996 Sep; 149(3):1055-62. PubMed ID: 8780407
[TBL] [Abstract][Full Text] [Related]
10. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115.
Noguchi S; Takatsuka D; Kitamura Y; Terada N; Uchida N; Yamaguchi K; Sato B; Matsumoto K
Cancer Res; 1985 Oct; 45(10):4785-90. PubMed ID: 4027967
[TBL] [Abstract][Full Text] [Related]
12. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
13. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
Emerman JT; Siemiatkowski J
Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
[TBL] [Abstract][Full Text] [Related]
14. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
15. Estrogen binding component in the pilosebaceous tumor developed in Suncus murinus.
Takayasu S; Itami S; Komada S; Kurata S
Endocrinol Jpn; 1988 Aug; 35(4):557-65. PubMed ID: 3215143
[TBL] [Abstract][Full Text] [Related]
16. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence.
Myers RB; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
J Urol; 2001 Mar; 165(3):1027-32. PubMed ID: 11176534
[TBL] [Abstract][Full Text] [Related]
18. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
19. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a transplantable hormone-responsive human prostatic cancer xenograft TEN12 and its androgen-resistant sublines.
Harper ME; Goddard L; Smith C; Nicholson RI
Prostate; 2004 Jan; 58(1):13-22. PubMed ID: 14673948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
